Clin Lab. 2021 Jul 1;67(7). doi: 10.7754/Clin.Lab.2020.200849.
To analyze the correlation of component blood transfusion and prognosis of patients with pregnancy-induced hypertension (PIH) and postpartum hemorrhage (PPH) in assisted reproductive technology (ART).
A retrospective analysis of clinical data on 85 pregnant women with ART-induced PIH and PPH was completed. They were divided into observation group and control group based on whether there was component transfusion after massive hemorrhage. The plasma coagulation and blood platelet-related indexes of the two groups of patients were assayed before blood transfusion, 24 hours after blood transfusion, and 12 weeks post-partum. The incidence of adverse reactions of blood transfusion within one week of blood transfusion, the proportion of patients transferred to the general ward, the blood pressure, and biochemical indexes at 12 weeks postpartum were recorded.
There was no significant difference in coagulation function before blood transfusion between the two groups of patients (p > 0.05). After 24 hours of massive blood transfusion, APTT, PT, and TT in the observation group were obviously shorter than those in the control group (p < 0.001), whereas FIB and PLT were higher than the control group (p < 0.01). In contrast to the control group at 12 weeks postpartum, the APTT, TT, and PT of the observation group were shortened (p < 0.05), while the FIB level was higher (p < 0.01). The probability of adverse reactions of transfusion in the observation group was lower than the control group (p < 0.05). The correlation between component transfusion and disease improvement after one week of transfusion and 12 weeks postpartum was 0.350 (0.159 - 0.530) (p < 0.01) and 0.441 (0.258 - 0.608) (p < 0.001).
Component blood transfusion in ART-induced PIH patients can improve their coagulation function, reduce the probability of adverse reactions caused by massive blood transfusion, and improve their prognosis.
分析辅助生殖技术(ART)中妊娠高血压(PIH)和产后出血(PPH)患者成分输血与预后的相关性。
回顾性分析 85 例 ART 致 PIH 和 PPH 患者的临床资料,根据大出血后是否进行成分输血分为观察组和对照组。检测两组患者输血前、输血后 24 小时及产后 12 周时的血浆凝血及血小板相关指标,记录输血后 1 周内不良反应的发生率、转入普通病房的比例、血压及产后 12 周时的生化指标。
两组患者输血前凝血功能比较差异无统计学意义(p>0.05)。观察组大量输血后 24 小时 APTT、PT、TT 明显短于对照组(p<0.001),而 FIB、PLT 高于对照组(p<0.01);观察组产后 12 周时 APTT、TT、PT 较对照组缩短(p<0.05),FIB 水平高于对照组(p<0.01)。观察组输血不良反应的概率低于对照组(p<0.05)。输血后 1 周及产后 12 周时,成分输血与疾病改善的相关性分别为 0.350(0.1590.530)(p<0.01)和 0.441(0.2580.608)(p<0.001)。
ART 致 PIH 患者进行成分输血可改善其凝血功能,降低大量输血所致不良反应的发生概率,改善其预后。